Csenge Advisory Group’s Balchem Corp BCPC Stock Holding History

Csenge Advisory Group’s Portfolio BCPC Stock Details BCPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,653	Closed	-$306K	–	534
2020 Q4	$306K	Buy	+2,653	New	+$280K	0.04%	316
2018 Q4	–	Sell	-10	Closed	–	–	1558
2018 Q3	$0	Buy	+10	New	+$1.05K	﹤0.01%	1696

Other funds holding BCPC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Csenge Advisory Group's BCPC Position: Q1 2021 in Review

Csenge Advisory Group sold out of Balchem Corp (BCPC) in Q1 2021, closing a stake of 2,653 shares — an estimated $306K sold.

Csenge Advisory Group first reported a position in BCPC in Q3 2018 and held it in 2 quarters. The position peaked at $306K in Q4 2020. 256 funds tracked by Wall St. Rank hold BCPC as of Q1 2021.

Csenge Advisory Group reported no remaining Balchem Corp position as of Q1 2021 after selling out during the quarter.
Csenge Advisory Group sold 2,653 Balchem Corp shares in Q1 2021, an estimated $306K.
Csenge Advisory Group first reported a position in Balchem Corp in Q3 2018 and held it in 2 quarters.
Csenge Advisory Group's Balchem Corp position peaked at $306K in Q4 2020.
256 funds tracked by Wall St. Rank held Balchem Corp as of Q1 2021.

Based on Csenge Advisory Group's 13F filing for Q1 2021, filed 28 Apr 2021.